Abstract
To investigate the role of interleukin-1 (IL-1) in lipopolysaccharide (LPS)-induced sickness behavior, rats were injected with recombinant human interleukin-1 receptor antagonist (IL-1ra), an endogenous cytokine able to block most of the biological effects of IL-1 both in vivo and in vitro. Intraperitoneal injection of IL-1ra (3 mg/rat) attenuated the depressive effect of LPS (250 μg/kg) on social exploration and body weight when both treatments were injected peripherally. Intracerebroventricular injection of IL-1ra (60 μg/rat) did not block the effects of peripherally injected LPS. These data indicate that the peripherally mediated effects of IL-1 account for a significant part of LPS-induced sickness behavior.
Original language | English (US) |
---|---|
Pages (from-to) | 318-320 |
Number of pages | 3 |
Journal | Brain Research |
Volume | 573 |
Issue number | 2 |
DOIs | |
State | Published - Feb 28 1992 |
Externally published | Yes |
Keywords
- Interleukin-1
- Interleukin-1 receptor antagonist
- Lipopolysaccharide
- Rat
- Social behavior
ASJC Scopus subject areas
- General Neuroscience
- Molecular Biology
- Clinical Neurology
- Developmental Biology